February 26, 2020 / 10:37 PM / a month ago

BRIEF-Oramed Pharmaceuticals Announces Proposed Public Offering Of Common Stock

Feb 26 (Reuters) - Oramed Pharmaceuticals Inc:

* ORAMED PHARMACEUTICALS INC. ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

* ORAMED PHARMACEUTICALS - INTENDS TO USE NET PROCEEDS OF OFFERING FOR ITS ANTICIPATED PHASE 3 CLINICAL TRIAL IN ORMD-0801 (ORAL INSULIN) Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below